Mechanisms of aging

Archives of Dermatology

Volumn 138, Issue 11, 2002, Pages 1429-1432

  Yaar, Mina ^a   Eller, Mark S ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLATION; AGING; APOPTOSIS; CELL LOSS; CELL PROLIFERATION; DNA DAMAGE; GENETIC ANALYSIS; LONGEVITY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SENESCENCE; TELOMERE;

EID: 0036846217     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.138.11.1429     Document Type: Review

References (59)

1. Campisi J. Replicative senescence: An old lives' tale? Cell. 1996;84:497-500.
2. Hasty P, Vijg J. Genomic priorities in aging. Science. 2002;296:1250-1251.
3. Bohr V. Repair of oxidative DNA damage in nuclear and mitochondrial DNA, and some changes with aging in mammalian cells. Free Radic Biol Med. 2002;32: 804-812.
4. Hart RW, Setlow RB. Correlation between deoxyribonucleic acid excision-repair and life-span in a number of mammalian species. Proc Natl Acad Sci U S A. 1974;71:2169-2173.
5. Sohal RS, Allen RG. Relationship between metabolic rate, free radicals, differentiation and aging: A unified theory. In: Woodhead AV, Blackett AD, Hollaender A, eds. The Molecular Biology of Aging. New York, NY: Plenum Press; 1985:75-104.
6. Hayflick L, Moorehead PS. The serial cultivation of human diploid cell strains. Exp Cell Res. 1961;25:585-621.
7. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res. 1965;37:614-636.
8. Schneider EL, Mitsui Y. The relationship between in vitro cellular aging and in vivo human age. Proc Natl Acad Sci U S A. 1976;73:3584-3588.
9. Martin GM, Sprague CA, Epstein CJ. Replicative life-span of cultivated human cells: Effects of donor's age, tissue, and genotype. Lab Invest. 1970;23:86-92.
10. Greider CW, Blackburn EW. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell. 1985;43:405-413.
11. Sharma HW, Sokoloski JA, Perez JR, Maltese JY, Sartorelli AC. Differentiation of immortal cells inhibits telomerase activity. Proc Natl Acad Sci U S A. 1995;92:12343-12346.
12. Allsopp RC, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A. 1992;89:10114-10118.
13. Ahmed A, Tollefsbol T. Telomeres and telomerase: Basic science implications for aging. J Am Geriatr Soc. 2001;49:1105-1109.
14. Harley CB, Kim NW, Prowse KR, et al. Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol. 1994;59:307-315.
15. Harley CB, Kim NW. Telomerase and cancer. In: DeVita VT, Hellman S, Rosenberg SA, eds. Important Advances in Oncology. Philadelphia, Pa: Lippincott-Raven; 1996:57-67.
16. Blackburn E. Telomere states and cell fates. Nature. 2000;408:53-56.
17. van Steensel B, Smogorewska A, de Lange T. TRF2 protects telomeres from end-to-end fusions. Cell. 1998;92:401-413.
18. Karlseder J, Broccoli D, Dai Y, Hardy S, de Lange T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science. 1999;283:1321-1325.
19. Eller MS, Puri N, Hadshiew IM, Venna SS, Gilchrest BA. Induction of apoptosis by telomere 3′ overhang specific DNA. Exp Cell Res. 2002;276:185-193.
20. Hadshiew IM, Eller MS, Gasparro FP, Gilchrest BA. Stimulation of melanogenesis by DNA oligonucleotides: Effect of size, sequence and 5′ phosphorylation. J Dermatol Sci. 2001;25:127-138.
21. Eller MS, Maeda T, Magnoni C, Atwal D, Gilchrest BA. Enhancement of DNA repair in human skin cells by thymidine dinucleotides: Evidence for a p53-mediated mammalian SOS response. Proc Natl Acad Sci U S A. 1997;94:12627-12632.
22. Li GZ, Eller MS, Gilchrest BA. Induction of replicative senescence markers by telomere 3′ overhang specific DNA [abstract]. J Invest Dermatol. 2001;117: 792.
23. Li GZ, Eller MS, Gilchrest BA. Evidence that senescence is due to exposure of telomere 3′ overhang specific DNA following critical telomere shortening [abstract]. J Invest Dermatol. In press.
24. Setlow RB, Carrier WL. Pyrimidine dimers in ultraviolet-irradiated DNAs. J Mol Biol. 1966;17:237-254.
25. Kasai H, Nishimura S. Formation of 8-hydroxydeoxyguanosine in DNA by oxygen radicals and its biological significance. In: Sies H, ed. Oxidative Stress: Oxidants and Antioxidants. London, England: Academic Press, Ltd; 1991:99-116.
26. Burstyn JN, Heiger-Bernays WJ, Cohen SM, Lippard SJ. Formation of cisdiamminedichloroplatinum(II) 1,2-intrastrand cross-links on DNA is flanking-sequence independent. Nucleic Acids Res. 2000;28:4237-4243.
27. Oikawa S, Kawanishi S. Site-specific DNA damage at GGG sequence by oxidative stress may accelerate telomere shortening. FEBS Lett. 1999;453:365-368.
28. Ishibashi T, Lippard SJ. Telomere loss in cells treated with cisplatin. Proc Natl Acad Sci U S A. 1998;95:4219-4223.
29. Kruk PA, Rampino NJ, Bohr VA. DNA damage and repair in telomeres: Relation to aging. Proc Natl Acad Sci U S A. 1995;92:258-262.
30. Abrahams PJ, Schouten R, van Laar T, Houweling A, Terleth C, van der Eb AJ. Different regulation of p53 stability in UV-irradiated normal and DNA repair deficient human cells. Mutat Res. 1995;336:169-180.
31. Tahara H, Tokutake Y, Maeda S, et al. Abnormal telomere dynamics of B-lymphoblastoid cell strains from Werner's syndrome patients transformed by Epstein-Barr virus. Oncogene. 1997;15:1911-1920.
32. Chen Q, Fischer A, Reagan JD, Yan LJ, Ames BN. Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc Natl Acad Sci U S A. 1995;92:4337-4341.
33. Kawanishi S, Hiraku Y, Oikawa S. Mechanism of guanine-specific DNA damage by oxidative stress and its role in carcinogenesis and aging. Mutat Res. 2001;488:65-76.
34. Robles SJ, Adami GR. Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts. Oncogene. 1998;16:1113-1123.
35. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 1997;88:593-602.
36. Bringold F, Serrano M. Tumor suppressors and oncogenes in cellular senescence. Exp Gerontol. 2000;35:317-329.
37. Zhu J, Woods D, McMahon M, Bishop JM. Senescence of human fibroblasts induced by oncogenic raf. Genes Dev. 1998;12:2997-3007.
38. Lin AW, Barradas M, Stone JC, van Aelst L, Serrano M, Lowe SW. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/ MAPK mitogenic signaling. Genes Dev. 1998;12:3008-3019.
39. Dimri GP, Itahana K, Acosta M, Campisi J. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14/ARF tumor suppressor. Mol Cell Biol. 2000;20:273-285.
40. McConnell BB, Starborg M, Brookes S, Peters G. Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Curr Biol. 1998;8:351-354.
41. Ranade K, Hussussian CJ, Sikorski RS, et al. Mutations associated with familial melanoma impair p16INK4 function. Nat Genet. 1995;10:114-116.
42. Itahana K, Dimri G, Campisi J. Regulation of cellular senescence by p53. Eur J Biochem. 2001;268:2784-2791.
43. Ogryzko W, Hirai TH, Russanova VR, Barbie DA, Howard BH. Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent. Mol Cell Biol. 1996;16:5210-5218.
44. Wagner M, Brosch G, Zwerschke W, Seto E, Loidl P, Jansen-Durr P. Histone deacetylases in replicative senescence: Evidence for a senescence-specific form of HDAC-2. FEBS Lett. 2001;499:101-106.
45. Dimri GP, Lee X, Basile G, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A. 1995;92:9363-9367.
46. Porter MB, Pereira-Smith OM, Smith JR. Common senescent cell-specific antibody epitopes on fibronectin in species and cells of varied origin. J Cell Physiol. 1992;150:545-551.
47. Zeng G, Millis AJ. Differential regulation of collagenase and stromelysin mRNA in late passage cultures of human fibroblasts. Exp Cell Res. 1996;222:150-156.
48. Khorramizadeh MR, Tredget EE, Telasky C, Shen Q, Ghahary A. Aging differentially modulates the expression of collagen and collagenase in dermal fibroblasts. Mol Cell Biochem. 1999;194:99-108.
49. Burke EM, Horton WE, Pearson JD, Crow MT, Martin GR. Altered transcriptional regulation of human interstitial collagenase in cultured skin fibroblasts from older donors. Exp Gerontol. 1994;29:37-53.
50. Weeda G, van Ham RC, Vermeulen W, Bootsma D, van der Eb AJ, Hoeijmakers JH. A presumed DNA helicase encoded by ERCC-3 is involved in the human repair disorders xeroderma pigmentosum and Cockayne's syndrome. Cell. 1990;62:777-791.
51. Troelstra C, van Gool A, de Wit J, Vermeulen W, Bootsma D, Hoeijmakers JH. ERCC6, a member of a subfamily of putative helicases, is involved in Cockayne's syndrome and preferential repair of active genes. Cell. 1992;71:939-953.
52. Savitsky K, Bar-Shira A, Gilad S, et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science. 1995;268:1749-1753.
53. Yu CE, Oshima J, Fu YH, et al. Positional cloning of the Werner's syndrome gene. Science. 1996;272:258-262.
54. Sun J, Kale SP, Childress AM, Pinswasdi C, Jazwinski SM. Divergent roles of RAS1 and RAS2 in yeast longevity. J Biol Chem. 1994;269:18638-18645.
55. Johnson TE. Aging can be genetically dissected into component processes using long-lived lines of Caenorhabditis elegans. Proc Natl Acad Sci U S A. 1987;84:3777-3781.
56. Dudas SP, Arking R. A coordinate upregulation of antioxidant gene activities is associated with the delayed onset of senescence in a long-lived strain of Drosophila. J Gerontol A Biol Sci Med Sci. 1995;50:B117-B127.
57. Jazwinski SM. Longevity, genes and aging. Science. 1996;273:54-59.
58. Covelli V, Mouton D, Di Maio V, et al. Inheritance of immune responsiveness, life span, and disease incidence in interline crosses of mice selected for high or low multispecific antibody production. J Immunol. 1989;142:1224-1234.
59. de Boer J, Andressoo JO, de Wit J, et al. Premature aging in mice deficient in DNA repair and transcription. Science. 2002;296:1276-1279.